1. 1881 Does agents sequencing matter across multiple line of chemotherapy in metastatic breast cancer? A mono-institutional retrospective analysis on 550 women. (September 2015) Authors: Bernardo, A.; Sottotetti, F.; Teragni, C.; Tagliaferri, B.; Licata, L.; Pozzi, E.; Palumbo, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real-world use of multigene signatures in early breast cancer: the experience by the Lombardy Genomic Assays for Breast Cancer Working Group. (November 2022) Authors: Licata, L.; Cosentini, D.; De Sanctis, R.; Iorfida, M.; Rota Cameroli, E.; Vingiani, A.; Simoncini, E.L.; Pruneri, G.; Munzone, E.; Bianchini, G.; Zambelli, A.; Tondini, C. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗